{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:25:52Z","timestamp":1788492352083,"version":"build-2803163510"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Tuberculosis (TB), caused by the <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (M.tb), remains a serious medical concern globally. Resistant M.tb strains are emerging, partly because M.tb can survive within alveolar macrophages, resulting in persistent infection. Protein kinase G (PknG) is a mycobacterial virulence factor that promotes the survival of M.tb in macrophages. Targeting PknG could offer an opportunity to suppress the resistant M.tb strains.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In the present study, multiple computational tools were adopted to screen a library of 460,000 molecules for potential inhibitors of PknG of M.tb.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and discussions<\/jats:title><jats:p>Seven Hits (<jats:bold>1\u20137<\/jats:bold>) were identified with binding affinities exceeding that of the reference compound (AX20017) towards the PknG catalytic domain. Next, the ADMETox studies were performed to identify the best hit with appropriate drug-like properties. The chromene glycoside (Hit <jats:bold>1<\/jats:bold>) was identified as a potential PknG inhibitor with better pharmacokinetic and toxicity profiles rendering it a potential drug candidate. Furthermore, quantum computational analysis was conducted to assess the mechanical and electronic properties of Hit <jats:bold>1,<\/jats:bold> providing guidance for further studies. Molecular dynamics simulations were also performed for Hit <jats:bold>1<\/jats:bold> against PknG, confirming the stability of its complex. In sum, the findings in the current study highlight Hit <jats:bold>1<\/jats:bold> as a lead with potential for development of drugs capable of treating resistant TB.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fchem.2025.1531152","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T06:55:13Z","timestamp":1740466513000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Molecular docking, free energy calculations, ADMETox studies, DFT analysis, and dynamic simulations highlighting a chromene glycoside as a potential inhibitor of PknG in Mycobacterium tuberculosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Muharib","family":"Alruwaili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilal","family":"Elsaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi Awadalla","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abozer Y.","family":"Elderdery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddiqa M. A.","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma Elhadi Ibrahim","family":"Mekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazim Abdullah","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maily J.","family":"Alrowily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Musleh","family":"Althobiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1145974","DOI":"10.3389\/fchem.2023.1145974","article-title":"Computational pharmacology and computational chemistry of 4-hydroxyisoleucine: physicochemical, pharmacokinetic, and DFT-based approaches","volume":"11","author":"Ahmad","year":"2023","journal-title":"Front. Chem."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fddsv.2023.1254656","article-title":"State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approach","volume":"3","author":"Akinnuwesi","year":"2023","journal-title":"Front. Drug Discov."},{"key":"B3","first-page":"1570","article-title":"DFT and in-silico investigations, along with in-vitro antitumor and antimicrobial assessments of pharmacological molecules","author":"Alsehli","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","first-page":"7646","DOI":"10.3390\/molecules26247646","article-title":"Naturally occurring chromone glycosides: sources, bioactivities, and spectroscopic features","volume":"26","author":"Amen","year":"2021","journal-title":"Molecules"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6261528","DOI":"10.1155\/2022\/6261528","article-title":"Pyridine-N-Oxide alkaloids from allium stipitatum and their synthetic disulfide analogs as potential drug candidates against Mycobacterium tuberculosis: a molecular docking, QSBAR, and ADMET prediction approach","volume":"2022","author":"Amengor","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1016\/j.bmc.2012.07.009","article-title":"Synthesis and evaluation of small libraries of triazolylmethoxy chalcones, flavanones and 2-aminopyrimidines as inhibitors of mycobacterial FAS-II and PknG","volume":"20","author":"Anand","year":"2012","journal-title":"Bioorg Med. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"20204","DOI":"10.1021\/acsomega.2c02093","article-title":"Identifying RO9021 as a potential inhibitor of PknG from Mycobacterium tuberculosis: combinative computational and in vitro studies","volume":"7","author":"Arica-Sosa","year":"2022","journal-title":"ACS Omega"},{"key":"B8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.procs.2019.08.181","article-title":"Structure of biomolecules through molecular dynamics simulations","volume":"156","author":"Arnittali","year":"2019","journal-title":"Procedia Comput. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1080\/07391102.2015.1077343","article-title":"Pharmacophore model prediction, 3D-QSAR and molecular docking studies on vinyl sulfones targeting Nrf2-mediated gene transcription intended for anti-Parkinson drug design","volume":"34","author":"Athar","year":"2016","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B10","article-title":"Targeting SARS-CoV-2 main protease by teicoplanin: a mechanistic insight by docking","volume-title":"MM\/GBSA and molecular dynamics simulation","author":"Azam","year":"2021"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/s2666-5247(22)00359-7","article-title":"WHO's global tuberculosis report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet Microbe"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e20230859","DOI":"10.1084\/jem.20230859","article-title":"A half-century of research on tuberculosis: successes and challenges","volume":"220","author":"Bloom","year":"2023","journal-title":"J. Exp. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/qua.24481","article-title":"Jaguar: a high-performance quantum chemistry software program with strengths in life and materials sciences","volume":"113","author":"Bochevarov","year":"2013","journal-title":"Int. J. Quantum Chem."},{"key":"B14","first-page":"84","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","volume-title":"Proceedings of the 2006 ACM\/IEEE conference on supercomputing","author":"Bowers","year":"2006"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s11224-022-02079-8","article-title":"In silico analyses of betulin: DFT studies, corrosion inhibition properties, ADMET prediction, and molecular docking with a series of SARS-CoV-2 and monkeypox proteins","volume":"34","author":"Burkhanova","year":"2022","journal-title":"Struct. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s10822-018-0173-3","article-title":"Mycobacterium tuberculosis serine\/threonine protein kinases: structural information for the design of their specific ATP-competitive inhibitors","volume":"32","author":"Caballero","year":"2018","journal-title":"J. Comput. Aided Mol. Des."},{"key":"B17","doi-asserted-by":"publisher","first-page":"10482","DOI":"10.3390\/ijms241310482","article-title":"Target identification in anti-tuberculosis drug discovery","volume":"24","author":"Capela","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tube.2017.01.001","article-title":"Sclerotiorin inhibits protein kinase G from Mycobacterium tuberculosis and impairs mycobacterial growth in macrophages","volume":"103","author":"Chen","year":"2017","journal-title":"Tuberculosis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1501240","DOI":"10.1126\/sciadv.1501240","article-title":"Regulation of protein-ligand binding affinity by hydrogen bond pairing","volume":"2","author":"Chen","year":"2016","journal-title":"Sci. Adv."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/j.1365-2958.2004.04085.x","article-title":"The Mycobacterium tuberculosis protein serine\/threonine kinase PknG is linked to cellular glutamate\/glutamine levels and is important for growth in vivo","volume":"52","author":"Cowley","year":"2004","journal-title":"Mol. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","article-title":"Anti-tuberculosis treatment strategies and drug development: challenges and priorities","volume":"20","author":"Dartois","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"30971","DOI":"10.1021\/acsomega.0c03848","article-title":"Structure-based scaffold Repurposing toward the discovery of novel cholinesterase inhibitors","volume":"5","author":"Dighe","year":"2020","journal-title":"ACS Omega"},{"key":"B23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41579-024-01025-1","article-title":"Drug-resistant tuberculosis: a persistent global health concern","volume":"22","author":"Farhat","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1021\/acs.jmedchem.2c00227","article-title":"Tuberculosis drug discovery: challenges and new horizons","volume":"65","author":"Fernandes","year":"2022","journal-title":"J. Med. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","article-title":"ADMET modeling approaches in drug discovery","volume":"24","author":"Ferreira","year":"2019","journal-title":"Drug Discov. Today"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/viru.22329","article-title":"Virulence factors of the Mycobacterium tuberculosis complex","volume":"4","author":"Forrellad","year":"2013","journal-title":"Virulence"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1001\/jama.2017.18477","article-title":"Tuberculosis update 2017","volume":"318","author":"Friedrich","year":"2017","journal-title":"Jama"},{"key":"B28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ddtec.2004.11.008","article-title":"Glide: a new approach for rapid, accurate docking and scoring","volume":"1","author":"Friesner","year":"2004","journal-title":"Drug Discov. Today. Technol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"B30","doi-asserted-by":"publisher","first-page":"107468","DOI":"10.1016\/j.vascn.2023.107468","article-title":"Off-target pharmacological activity at various kinases: potential functional and pathological side effects","volume":"123","author":"Green","year":"2023","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2023.2213336","article-title":"2-Hydroxymethyl-18-crown-6 as an efficient organocatalyst for alpha-aminophosphonates synthesized under eco-friendly conditions, DFT, molecular docking and ADME\/T studies","author":"Guezane-Lakoud","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B32","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2","volume-title":"Enrichment factors in database screening","author":"Halgren","year":"2024"},{"key":"B33","first-page":"163","article-title":"Chapter Three - the importance of plasma protein and tissue binding in a drug discovery program to successfully deliver a preclinical candidate","volume-title":"Progress in medicinal chemistry","author":"Hann","year":"2022"},{"key":"B34","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/s0022-2836(02)00470-9","article-title":"On the role of the crystal environment in determining protein side-chain conformations","volume":"320","author":"Jacobson","year":""},{"key":"B35","first-page":"1097","volume-title":"A hierarchical approach to all-atom protein loop prediction","author":"Jacobson","year":""},{"key":"B36","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3389\/fmicb.2018.01517","article-title":"Identification of novel mycobacterial inhibitors against mycobacterial protein kinase G","volume":"9","author":"Kanehiro","year":"2018","journal-title":"Front. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"100712","DOI":"10.1016\/j.chphi.2024.100712","article-title":"Investigation of antibacterial and antifungal properties of benzene sulfonamide derivatives by experimental and computational studies","volume":"9","author":"Kap\u0131suz","year":"2024","journal-title":"Chem. Phys. Impact"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6759","DOI":"10.1080\/07391102.2022.2112078","article-title":"Atom-based 3D-QSAR and DFT analysis of 5-substituted 2-acylaminothiazole derivatives as HIV-1 latency-reversing agents","volume":"41","author":"Khan","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B39","doi-asserted-by":"publisher","first-page":"16093","DOI":"10.1074\/jbc.M117.797563","article-title":"Protein kinase G confers survival advantage to Mycobacterium tuberculosis during latency-like conditions","volume":"292","author":"Khan","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/iub.1871","article-title":"Targeting the messengers: serine\/threonine protein kinases as potential targets for antimycobacterial drug development","volume":"70","author":"Khan","year":"2018","journal-title":"IUBMB Life"},{"key":"B41","doi-asserted-by":"publisher","first-page":"009966","DOI":"10.1128\/AAC.00996-19","article-title":"NU-6027 inhibits growth of Mycobacterium tuberculosis by targeting protein kinase D and protein kinase G","volume":"63","author":"Kidwai","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"A1697","DOI":"10.1103\/PhysRev.137.A1697","article-title":"Quantum density oscillations in an inhomogeneous electron gas","volume":"137","author":"Kohn","year":"1965","journal-title":"Phys. Rev."},{"key":"B43","first-page":"1350","volume-title":"Serine\/threonine protein kinases PknF and PknG of Mycobacterium tuberculosis: characterization and localization","author":"Koul","year":"2001"},{"key":"B44","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2174\/1570179420666230316094435","article-title":"An insight on the prospect of quinazoline and quinazolinone derivatives as anti-tubercular agents","volume":"20","author":"Kushwaha","year":"2023","journal-title":"Curr. Org. Synth."},{"key":"B45","doi-asserted-by":"publisher","first-page":"20387","DOI":"10.1074\/jbc.M116.743138","article-title":"The human ether-a-go-go-related gene (hERG) potassium channel represents an unusual target for protease-mediated damage","volume":"291","author":"Lamothe","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.slasd.2022.12.003","article-title":"Using chemical and biological data to predict drug toxicity","volume":"28","author":"Liu","year":"2023","journal-title":"SLAS Discov."},{"key":"B47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jtbi.2017.11.021","article-title":"Exploration of Mycobacterium tuberculosis structural proteome: an in-silico approach","volume":"439","author":"Lone","year":"2018","journal-title":"J. Theor. Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/molecules25030665","article-title":"In silico strategies in tuberculosis drug discovery","volume":"25","author":"Macalino","year":"2020","journal-title":"Molecules"},{"key":"B49","author":"Maestro","year":"2023"},{"key":"B50","first-page":"2193","volume-title":"An in silico evaluation of the ADMET profile of the StreptomeDB database","author":"Ntie-Kang","year":"2013"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/j.1365-2958.2008.06489.x","article-title":"Regulation of glutamate metabolism by protein kinases in mycobacteria","volume":"70","author":"O'Hare","year":"2008","journal-title":"Mol. Microbiol."},{"key":"B52","author":"QikProp","year":"2023"},{"key":"B53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s13205-023-03595-y","article-title":"Evaluation of therapeutic potentials of selected phytochemicals against Nipah virus, a multi-dimensional in silico study","volume":"13","author":"Rababi","year":"2023","journal-title":"3 Biotech."},{"key":"B54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s40203-021-00102-0","article-title":"In silico DFT study, molecular docking, and ADMET predictions of cytidine analogs with antimicrobial and anticancer properties","volume":"9","author":"Rana","year":"2021","journal-title":"Silico Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e1007975","DOI":"10.1371\/journal.ppat.1007975","article-title":"Tuberculosis drug discovery in the CRISPR era","volume":"15","author":"Rock","year":"2019","journal-title":"PLoS Pathog."},{"key":"B56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1128\/CMR.00042-07","article-title":"Central nervous system tuberculosis: pathogenesis and clinical aspects","volume":"21","author":"Rock","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.1080\/07391102.2022.2123396","article-title":"In silico approach identified benzoylguanidines as SARS-CoV-2 main protease (M(pro)) potential inhibitors","volume":"41","author":"Santiago-Silva","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B58","first-page":"1573","volume-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","author":"Sastry","year":"2013"},{"key":"B59","doi-asserted-by":"publisher","first-page":"12151","DOI":"10.1073\/pnas.0702842104","article-title":"Structural basis for the specific inhibition of protein kinase G, a virulence factor of Mycobacterium tuberculosis","volume":"104","author":"Scherr","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B60","author":"Schr\u00f6dinger Release","year":"2023"},{"key":"B61","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41577-018-0025-3","article-title":"Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection","volume":"18","author":"Simmons","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1021\/acs.jcim.5b00150","article-title":"Identification of novel inhibitors of Mycobacterium tuberculosis PknG using pharmacophore based virtual screening, docking, molecular dynamics simulation, and their biological evaluation","volume":"55","author":"Singh","year":"2015","journal-title":"J. Chem. Inf. Model"},{"key":"B63","doi-asserted-by":"publisher","first-page":"a017822","DOI":"10.1101\/cshperspect.a017822","article-title":"Tuberculosis treatment and drug regimens","volume":"5","author":"Sotgiu","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2100224","DOI":"10.1002\/ardp.202100224","article-title":"1, 5\u2010Benzoxazepines as a unique and potent scaffold for activity drugs: a review","volume":"354","author":"Stefaniak","year":"2021","journal-title":"Arch. Pharm."},{"key":"B65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ejoc.201601264","article-title":"Convenient synthesis of 3\u2010glycosylated isocoumarins","volume":"2017","author":"Sudarshan","year":"2017","journal-title":"Eur. J. Org. Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e202400380","DOI":"10.1002\/asia.202400380","article-title":"Recent advances in the synthesis of diarylheptanoids","volume":"19","author":"Sudarshan","year":"2024","journal-title":"Chem. Asian J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"11885","DOI":"10.1080\/07391102.2021.1965913","article-title":"Flavanones: a potential natural inhibitor of the ATP binding site of PknG of Mycobacterium tuberculosis","volume":"40","author":"Swain","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B68","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/ph16040484","article-title":"Recent advances in anti-tuberculosis drug discovery based on hydrazide-hydrazone and thiadiazole derivatives targeting InhA","volume":"16","author":"Teneva","year":"2023","journal-title":"Pharm. (Basel)"},{"key":"B69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-12-803620-4.00003-7","article-title":"Chapter 3 - ADME in drug discovery","volume-title":"A comprehensive guide to toxicology in nonclinical drug development","author":"Vrbanac","year":"2017"},{"key":"B70","first-page":"1520","volume-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","author":"Wang","year":"2019"},{"key":"B71","doi-asserted-by":"publisher","first-page":"116785","DOI":"10.1016\/j.ejmech.2024.116785","article-title":"Recent advances and challenges of revolutionizing drug-resistant tuberculosis treatment","volume":"277","author":"Wei","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"B72","first-page":"2020","article-title":"Global tuberculosis report 2020","author":"Who","year":"2020","journal-title":"Glob. Tuberc. Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/cid\/ciaa1064","article-title":"Multidrug resistant tuberculosis with simultaneously acquired drug resistance to bedaquiline and Delamanid","volume":"73","author":"Yoshiyama","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B75","first-page":"1873","volume-title":"Quantum mechanical methods for drug design","author":"Zhou","year":"2010"}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2025.1531152\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T06:55:20Z","timestamp":1740466520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2025.1531152\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":75,"alternative-id":["10.3389\/fchem.2025.1531152"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2025.1531152","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"article-number":"1531152"}}